Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Feeling abnormal? 283 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 283 reports of Feeling abnormal have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.8% of all adverse event reports for EMPAGLIFLOZIN.

283
Reports of Feeling abnormal with EMPAGLIFLOZIN
0.8%
of all EMPAGLIFLOZIN reports
1
Deaths
44
Hospitalizations

How Dangerous Is Feeling abnormal From EMPAGLIFLOZIN?

Of the 283 reports, 1 (0.4%) resulted in death, 44 (15.5%) required hospitalization, and 12 (4.2%) were considered life-threatening.

Is Feeling abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 283 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Feeling abnormal?

ADALIMUMAB (4,860) ETANERCEPT (4,533) PREGABALIN (4,451) SODIUM OXYBATE (3,018) DULOXETINE (2,875) TREPROSTINIL (2,704) TERIPARATIDE (2,673) LEVOTHYROXINE (2,671) SACUBITRIL\VALSARTAN (2,595) TOFACITINIB (2,533)

Which EMPAGLIFLOZIN Alternatives Have Lower Feeling abnormal Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Feeling abnormal Reports All Drugs Causing Feeling abnormal EMPAGLIFLOZIN Demographics